You are here: Industry Insights > Salix

News List

Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At The American Society For Pain Management Nursing (ASPMN) 31st National Conference prnewswire
October 13, 2021
Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, announced today...
Salix Will Share TRULANCE® (Plecanatide) Data At The 2021 AANP National Conference prnewswire
June 16, 2021
Salix Pharmaceuticals ("Salix"),announced today that data featuring TRULANCE® (plecanatide) will be shared at the American Association of Nurse Practitioners' (AANP) 2021 AANP National Conference, which takes place virtually June 15 through Aug. 31, 2021.
Salix partners with Mitsubishi Tanabe Pharma to market IBD drug biospectrumasia
April 28, 2019
Collaboration to develop and commercialize late stage investigational S1P modulator for the treatment of Inflammatory Bowel Disease (IBD)
Salix's giant inflatable 'Captain Colon' embarks on colon health awareness tour fiercepharma
March 05, 2019
The inflatable stolen colon is back—in triplicate. Salix Pharmaceutical employees donated money to the Colon Cancer Coalition to purchase a replacement after the company's 10-foot-tall inflatable teaching tool was stolen last October. Quest Diagnostics ma
Cosmo’s diarrhoea drug approved, threatening Salix’ cash cow pharmaphorum
November 27, 2018
Ireland’s Cosmo Pharma claimed FDA approval for its traveller’s diarrhoea drug Aemcolo, which some analysts say could be a big threat to a rival drug sold by Bausch Health’s Salix unit.
Salix Expands Research, Discovery Collaboration with Cedars-Sinai americanpharmaceuticalreview
August 06, 2018
Salix announced its affiliate has entered into a research agreement with Cedars-Sinai Medical Center to further investigate the microbiome in the treatment of GI disorders.